DOCSLIB.ORG

Dissecting the Genetic Architecture of Cardiac Disorders Through the Use Of

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Dissecting the genetic architecture of cardiac disorders through the use of High Throughput Sequencing. Author: Cian Murphy Supervisors: Dr. Vincent Plagnol Dr. Pier Lambiase UCL Genetics Institute Department of Genetics, Evolution and Environment October 9, 2016 I, Cian Murphy confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. i Abstract The overriding goal of this thesis was to further refine our understanding of the genetic architecture of car- diomyopathies, Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Hypertrophic Cardiomy- opathy (HCM). 407 patients with ARVC and 957 with HCM had 41 cardiomyopathy and other putative candidate genes sequenced. By comparing these cohorts against each other and against ethnicity and phe- notype matched controls, insights were gained into the role of different types of genetic variants in these conditions. This in part involved utilising 4500 Whole Exome Sequences (WES) that are part of the UCL- exomes consortium, an in-house dataset that aggregates a diverse set of studies. High throughput DNA sequencing technologies, WES or Whole Genome Sequencing (WGS) are revolutionizing the diagnosis and novel gene discovery for rare disorders. As the field transitions from the early discovery for Mendelian and near Mendelian diseases to more complex and oligo-genic diseases, there is substantial benefit in being able to combine data across studies, performing the type of meta-analysis for cases and controls that have proven to be so successful for Genome-Wide Association Studies (GWAS). However, WGS and WES are substantially more affected by sequencing errors and technical artefacts than genome-wide genotyping arrays. As a consequence, meta-analysis of sequence based association studies are often dominated by spurious associations, which result in technical limitations. Here, we show that it is possible to take advantage of the type of mixed models developed initially to control for population structure in GWAS studies, and apply these ideas to control for technical artefacts. In an attempt to ascertain the role of CNVs in HCM, these data were examined for the presence i of rare causative CNVs. 12 CNVs were identified from an initial Read Depth approach. 4 of these were subsequently validated by CoNIFER, a bioinformatics method, and Array Comparative Genomic Hybridis- ation (aCGH): one large deletion in MYBPC3, one large deletion in PDLIM3, one duplication of the entire TNNT2 gene and one large duplication in LMNA. These results show that the role of CNVs in HCM is small and highlight the efficiency of this two step-strategy. ii Acknowledgements Firstly, I would like to thank my primary supervisor, Dr. Vincent Plagnol. He has provided support from before day one and throughout on statistics to programming and how to do everything else. Apart from technical knowledge, the most lasting thing I feel I have learned is a never ending scepticism of the data, regardless of the pvalue. My secondary supervisor, Dr. Pier Lambiase offered excellent help on the clinical interpretation of the data alongside general life advice. Dr. Doug Speed of LDAK fame was an immense help in the latter stages of the PhD. I learned a lot more about statistics than I thought I could because of you. Warren, Chris, Lucy, Kitty, Shush, Elvira, Jon, Gareth, Valentina and Julie were some of the best group members I could ask for. From bug catching to the 3.30 coffee routine, you all made it fun to come into UGI. I'll miss you. I want to thank Daniel, my housemate and fellow PhD student. It was always useful to be able to compare PhDs and brainstorm over dinner. And a hefty amount of tennis and bomberman helped keep me somewhat sane. The tail end of my PhD was one of the hardest periods of my life. Writing up made me realise how much more I had to and combined with starting medical school resulted in a pretty serious coffee addiction. Noor, thank you so much for putting up with me. Too much help to list, but your humour, patience and food definitely deserve mentions. Best proof reader ever. I don't need a PhD in genetics to know that I couldn't have gotten here without my parents. Tirelessly supportive, I love you and thank you for giving me the freedom and encouragement to do what iii I wanted. Cillian, thank you for helping me with photoshop; there are somethings that even R cannot do it would seem and you were always willing to help me tweak figures until I realised what I wanted. Oisin, you're one of the smartest people I know and as my older brother you were always good at teaching me. Whether or not I wanted to learn. It was an honour to get to work somewhere the calibre of UCL. Being surrounded by the best researchers I have ever met is the most stimulating environment I could ask for. Lastly, thank you to the British Heart Foundation for being such a good supporter. iv Publications arising from this thesis 1. Panagiotis I Sergouniotis, Christina Chakarova, Cian Murphy, Mirjana Becker, Eva Lenassi, Gavin Arno, Monkol Lek, Daniel G Macarthur, Shomi S Bhattacharya, Anthony T Moore, Graham E Holder, An- thony G Robson, Uwe Wolfrum, Andrew R Webster, and Vincent Plagnol. AJHG The American Journal of Human Genetics Biallelic variants in TTLL5 , encoding a tubulin glutamylase , cause retinal dystrophy. American journal of human genetics, 94(5):760769, 2014. 2. Laurence M. Nunn, Luis R. Lopes, Petros Syrris, Cian Murphy, Vincent Plagnol, Eileen Firman, Chrysoula Dalageorgou, Esther Zorio, Diana Domingo, Victoria Murday, Iain Findlay, Alexis Duncan, Gerry Carr-White, Leema Robert, Tela Bueser, Caroline Langman, Simon P Fynn, Martin Goddard, Anne White, Henning Bundgaard, Laura Ferrero-Miliani, Nigel Wheeldon, Simon K. Suvarna, Aliceson O'Beirne, Martin D. Lowe, William J. McKenna, Perry M. Elliott, and Pier D. Lambiase. Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing. Europace, page euv285, 2015. ISSN 1099-5129. doi: 10.1093/europace/euv285. U 3. L.R. Lopes, C. Murphy, P. Syrris, C. Dalageorgou, W.J. McKenna, P.M. Elliott, and V. Plagnol. Use of High-throughput Targeted Exome-Sequencing to screen for Copy Number Variation in Hypertrophic Cardiomyopathy. European Journal of Medical Genetics, pages 16, 2015. ISSN 17697212. doi: 10.1016/j.ejmg.2015.10.001. v Acronyms MYBPC3 Myosin Binding Protein Cardiac 3. 6, 49, 51 RPGR Retinitis Pigmentosa GTPase Regulator. 66 TTLL5 Tubulin Tyrosine Ligase-Like family member 5. 66 1KG 1000 Genome Project. 73 aCGH Array Comparative Genome Hybridisation. 1, 40, 41, 43, 45, 46, 51{62 ArtQ Artefact. 14, 15 ARVC Arrhythmogenic Right Ventricular Cardiomyopathy. 1{3, 6, 7, 19, 21, 24, 28{31, 34, 35, 37, 40, 41, 66, 105, 109, 110, 115 CA Cochran Armitage. 12 CBS Circular Binary Segmentation. 43, 51{62 CGH Comparative Genome Hybridisation. 43 CNV Copy Number Variant. 1, 3, 19, 40, 42, 45, 49, 63, 77 CR Cryptic Relatedness. 65, 77 CV Corrected Variant. 95 vi DCM Dilated Cardiomyopathy. 41, 64 ECG Electrocardiogram. 41 EMMA Efficient Mixed Model Association. 17 ExAC Exome Aggregation Consortium. 23 FFPE Formalin Fixed Paraffin Embedded. 36 FPL2 Familial Partial Lipodystrophy 2. 64 GATK Genome Analysis Tool Kit https://www.broadinstitute.org/gatk. 17, 18 GC Genomic Control. 8, 12, 13 GIF Genomic Inflation Factor. 98 GWAS Genome Wide Association Study. 2, 16, 81, 126 HCM Hypertrophic Cardiomyopathy. 1, 6, 7, 19, 21, 24, 28{31, 34, 35, 37, 40{42, 63, 64, 66, 109, 110 HLA Human Leukocyte Antigen. 8 HMM Hidden Markov Model. 45 HTS High Throughput Sequencing. 1, 10, 11, 14, 19, 65, 66, 71, 77, 92 HWE Hardy-Weinberg Equilibrium. 81 IBD Inflammatory Bowel Disease. 99, 100 INDEL Insertions-Deletion. 11, 18, 66, 108, 110 LMM Linear Mixed Model. 15, 16, 66, 78, 79, 82, 112 LOF Loss of Function - frameshift and stop-gain or stop loss. 29, 40, 66, 68 vii MAF Minor Alelle Frequency. 2, 3, 22, 23, 29, 38, 40, 81, 85, 86, 98, 105 MHC Myosin Heavy Chain. 6 MLPA Multiplex Ligation-Dependent Probe Amplification. 63 PC Principal Component. 10, 65, 67, 73, 77{79, 82, 88, 91, 92, 95, 102, 107, 110 PCA Principal Component Analysis. 9, 10, 43, 65{69, 73, 88, 91, 92, 102, 107, 108, 110{112 PCR Polymerase Chain Reaction. 77 PID Primary ImmunoDeficiency. 89 PS Population Stratification. 8, 10, 15, 65, 73, 77, 82, 85, 99, 117, 121, 126 QTL Quantitative Trait Loci. 82 RD Read Depth. 1, 4, 37, 40, 42, 49, 63, 66, 77, 78, 81, 82, 92{94, 111, 112 REML Restricted Maximum Likelihood. 82 RPKM Reads per kilobase per milllion. 43 RRM Realized Relationship Matrix. 16 SADS Sudden Arrhythmic Death Syndrome. 6, 22, 127 SCD Sudden Cardiac Death. 2, 5{7, 19, 21, 28, 36, 37, 84, 114 SKAT Sequence Kernel Association Test. 27, 29 SKAT-O Sequence Kernel Association Test Optimised. 27 SNP Single Nucleotide Polymorphism. 3, 4, 16, 18, 19, 41, 63, 66, 72, 73, 79, 98, 108, 110, 111, 115, 120 SVD Singular Value Decomposition. 43 viii TK Technical Kinship. 66, 81 UCL-ex UCL Exome Consortium. 1, 17{21, 36, 37, 66, 67, 69, 71{75, 79, 81, 83, 84, 87, 91{95, 98{100, 103, 104, 106, 107, 109, 111{114, 116, 118, 125 VCE Variance Component Estimation. 82 VQSR Variant Quality Score Recalibration. 18 WES Whole Exome Sequencing. 2, 4, 12, 125, 126 WGS Whole Genome Sequencing. 2, 4 ix List of Figures 1.1 Overview of various DNA capture methods . .5 1.2 Comparison of a normal heart to one with Hypertrophic Cardiomyopathy .
Recommended publications
  • Refinement and Discovery of New Hotspots of Copy-Number Variation

    Refinement and Discovery of New Hotspots of Copy-Number Variation

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector ARTICLE Refinement and Discovery of New Hotspots of Copy-Number Variation Associated with Autism Spectrum Disorder Santhosh Girirajan,1,5 Megan Y. Dennis,1,5 Carl Baker,1 Maika Malig,1 Bradley P. Coe,1 Catarina D. Campbell,1 Kenneth Mark,1 Tiffany H. Vu,1 Can Alkan,1 Ze Cheng,1 Leslie G. Biesecker,2 Raphael Bernier,3 and Evan E. Eichler1,4,* Rare copy-number variants (CNVs) have been implicated in autism and intellectual disability. These variants are large and affect many genes but lack clear specificity toward autism as opposed to developmental-delay phenotypes. We exploited the repeat architecture of the genome to target segmental duplication-mediated rearrangement hotspots (n ¼ 120, median size 1.78 Mbp, range 240 kbp to 13 Mbp) and smaller hotspots flanked by repetitive sequence (n ¼ 1,247, median size 79 kbp, range 3–96 kbp) in 2,588 autistic individuals from simplex and multiplex families and in 580 controls. Our analysis identified several recurrent large hotspot events, including association with 1q21 duplications, which are more likely to be identified in individuals with autism than in those with developmental delay (p ¼ 0.01; OR ¼ 2.7). Within larger hotspots, we also identified smaller atypical CNVs that implicated CHD1L and ACACA for the 1q21 and 17q12 deletions, respectively. Our analysis, however, suggested no overall increase in the burden of smaller hotspots in autistic individuals as compared to controls. By focusing on gene-disruptive events, we identified recurrent CNVs, including DPP10, PLCB1, TRPM1, NRXN1, FHIT, and HYDIN, that are enriched in autism.
  • Environmental Influences on Endothelial Gene Expression

    Environmental Influences on Endothelial Gene Expression

    ENDOTHELIAL CELL GENE EXPRESSION John Matthew Jeff Herbert Supervisors: Prof. Roy Bicknell and Dr. Victoria Heath PhD thesis University of Birmingham August 2012 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Tumour angiogenesis is a vital process in the pathology of tumour development and metastasis. Targeting markers of tumour endothelium provide a means of targeted destruction of a tumours oxygen and nutrient supply via destruction of tumour vasculature, which in turn ultimately leads to beneficial consequences to patients. Although current anti -angiogenic and vascular targeting strategies help patients, more potently in combination with chemo therapy, there is still a need for more tumour endothelial marker discoveries as current treatments have cardiovascular and other side effects. For the first time, the analyses of in-vivo biotinylation of an embryonic system is performed to obtain putative vascular targets. Also for the first time, deep sequencing is applied to freshly isolated tumour and normal endothelial cells from lung, colon and bladder tissues for the identification of pan-vascular-targets. Integration of the proteomic, deep sequencing, public cDNA libraries and microarrays, delivers 5,892 putative vascular targets to the science community.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Ingenuity Pathway Analysis of Differentially Expressed Genes Involved in Signaling Pathways and Molecular Networks in Rhoe Gene‑Edited Cardiomyocytes

    Ingenuity Pathway Analysis of Differentially Expressed Genes Involved in Signaling Pathways and Molecular Networks in Rhoe Gene‑Edited Cardiomyocytes

    INTERNATIONAL JOURNAL OF MOleCular meDICine 46: 1225-1238, 2020 Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene‑edited cardiomyocytes ZHONGMING SHAO1*, KEKE WANG1*, SHUYA ZHANG2, JIANLING YUAN1, XIAOMING LIAO1, CAIXIA WU1, YUAN ZOU1, YANPING HA1, ZHIHUA SHEN1, JUNLI GUO2 and WEI JIE1,2 1Department of Pathology, School of Basic Medicine Sciences, Guangdong Medical University, Zhanjiang, Guangdong 524023; 2Hainan Provincial Key Laboratory for Tropical Cardiovascular Diseases Research and Key Laboratory of Emergency and Trauma of Ministry of Education, Institute of Cardiovascular Research of The First Affiliated Hospital, Hainan Medical University, Haikou, Hainan 571199, P.R. China Received January 7, 2020; Accepted May 20, 2020 DOI: 10.3892/ijmm.2020.4661 Abstract. RhoE/Rnd3 is an atypical member of the Rho super- injury and abnormalities, cell‑to‑cell signaling and interaction, family of proteins, However, the global biological function and molecular transport. In addition, 885 upstream regulators profile of this protein remains unsolved. In the present study, a were enriched, including 59 molecules that were predicated RhoE‑knockout H9C2 cardiomyocyte cell line was established to be strongly activated (Z‑score >2) and 60 molecules that using CRISPR/Cas9 technology, following which differentially were predicated to be significantly inhibited (Z‑scores <‑2). In expressed genes (DEGs) between the knockout and wild‑type particular, 33 regulatory effects and 25 networks were revealed cell lines were screened using whole genome expression gene to be associated with the DEGs. Among them, the most signifi- chips. A total of 829 DEGs, including 417 upregulated and cant regulatory effects were ‘adhesion of endothelial cells’ and 412 downregulated, were identified using the threshold of ‘recruitment of myeloid cells’ and the top network was ‘neuro- fold changes ≥1.2 and P<0.05.
  • Novel Rheumatoid Arthritis Susceptibility Locus at 22Q12 Identified in an Extended UK Genome-Wide Association Study

    Novel Rheumatoid Arthritis Susceptibility Locus at 22Q12 Identified in an Extended UK Genome-Wide Association Study

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE ARTHRITIS & RHEUMATOLOGY provided by Aberdeen University Research Archive Vol. 66, No. 1, January 2014, pp 24–30 DOI 10.1002/art.38196 © 2014 The Authors. Arthritis & Rheumatology is published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Novel Rheumatoid Arthritis Susceptibility Locus at 22q12 Identified in an Extended UK Genome-Wide Association Study Gisela Orozco,1 Sebastien Viatte,1 John Bowes,1 Paul Martin,1 Anthony G. Wilson,2 Ann W. Morgan,3 Sophia Steer,4 Paul Wordsworth,5 Lynne J. Hocking,6 UK Rheumatoid Arthritis Genetics Consortium, Wellcome Trust Case Control Consortium, Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Consortium, Anne Barton,1 Jane Worthington,1 and Stephen Eyre1 Objective. The number of confirmed rheumatoid extend our previous RA GWAS in a UK cohort, adding arthritis (RA) loci currently stands at 32, but many lines more independent RA cases and healthy controls, with of evidence indicate that expansion of existing genome- the aim of detecting novel association signals for sus- wide association studies (GWAS) enhances the power to ceptibility to RA in a homogeneous UK cohort. detect additional loci. This study was undertaken to Methods. A total of 3,223 UK RA cases and 5,272 UK controls were available for association analyses, Funding to generate the genome-wide association study data with the extension adding 1,361 cases and 2,334 controls was provided by Arthritis Research UK (grant 17552), Sanofi-Aventis, to the original GWAS data set.
  • Mir-17-92 Fine-Tunes MYC Expression and Function to Ensure

    Mir-17-92 Fine-Tunes MYC Expression and Function to Ensure

    ARTICLE Received 31 Mar 2015 | Accepted 22 Sep 2015 | Published 10 Nov 2015 DOI: 10.1038/ncomms9725 OPEN miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth Marija Mihailovich1, Michael Bremang1, Valeria Spadotto1, Daniele Musiani1, Elena Vitale1, Gabriele Varano2,w, Federico Zambelli3, Francesco M. Mancuso1,w, David A. Cairns1,w, Giulio Pavesi3, Stefano Casola2 & Tiziana Bonaldi1 The synergism between c-MYC and miR-17-19b, a truncated version of the miR-17-92 cluster, is well-documented during tumor initiation. However, little is known about miR-17-19b function in established cancers. Here we investigate the role of miR-17-19b in c-MYC-driven lymphomas by integrating SILAC-based quantitative proteomics, transcriptomics and 30 untranslated region (UTR) analysis upon miR-17-19b overexpression. We identify over one hundred miR-17-19b targets, of which 40% are co-regulated by c-MYC. Downregulation of a new miR-17/20 target, checkpoint kinase 2 (Chek2), increases the recruitment of HuR to c- MYC transcripts, resulting in the inhibition of c-MYC translation and thus interfering with in vivo tumor growth. Hence, in established lymphomas, miR-17-19b fine-tunes c-MYC activity through a tight control of its function and expression, ultimately ensuring cancer cell homeostasis. Our data highlight the plasticity of miRNA function, reflecting changes in the mRNA landscape and 30 UTR shortening at different stages of tumorigenesis. 1 Department of Experimental Oncology, European Institute of Oncology, Via Adamello 16, Milan 20139, Italy. 2 Units of Genetics of B cells and lymphomas, IFOM, FIRC Institute of Molecular Oncology Foundation, Milan 20139, Italy.
  • The Correlation of Keratin Expression with In-Vitro Epithelial Cell Line Differentiation

    The Correlation of Keratin Expression with In-Vitro Epithelial Cell Line Differentiation

    The correlation of keratin expression with in-vitro epithelial cell line differentiation Deeqo Aden Thesis submitted to the University of London for Degree of Master of Philosophy (MPhil) Supervisors: Professor Ian. C. Mackenzie Professor Farida Fortune Centre for Clinical and Diagnostic Oral Science Barts and The London School of Medicine and Dentistry Queen Mary, University of London 2009 Contents Content pages ……………………………………………………………………......2 Abstract………………………………………………………………………….........6 Acknowledgements and Declaration……………………………………………...…7 List of Figures…………………………………………………………………………8 List of Tables………………………………………………………………………...12 Abbreviations….………………………………………………………………..…...14 Chapter 1: Literature review 16 1.1 Structure and function of the Oral Mucosa……………..…………….…..............17 1.2 Maintenance of the oral cavity...……………………………………….................20 1.2.1 Environmental Factors which damage the Oral Mucosa………. ….…………..21 1.3 Structure and function of the Oral Mucosa ………………...….……….………...21 1.3.1 Skin Barrier Formation………………………………………………….……...22 1.4 Comparison of Oral Mucosa and Skin…………………………………….……...24 1.5 Developmental and Experimental Models used in Oral mucosa and Skin...……..28 1.6 Keratinocytes…………………………………………………….….....................29 1.6.1 Desmosomes…………………………………………….…...............................29 1.6.2 Hemidesmosomes……………………………………….…...............................30 1.6.3 Tight Junctions………………………….……………….…...............................32 1.6.4 Gap Junctions………………………….……………….….................................32
  • Looking for Missing Proteins in the Proteome Of

    Looking for Missing Proteins in the Proteome Of

    Looking for Missing Proteins in the Proteome of Human Spermatozoa: An Update Yves Vandenbrouck, Lydie Lane, Christine Carapito, Paula Duek, Karine Rondel, Christophe Bruley, Charlotte Macron, Anne Gonzalez de Peredo, Yohann Coute, Karima Chaoui, et al. To cite this version: Yves Vandenbrouck, Lydie Lane, Christine Carapito, Paula Duek, Karine Rondel, et al.. Looking for Missing Proteins in the Proteome of Human Spermatozoa: An Update. Journal of Proteome Research, American Chemical Society, 2016, 15 (11), pp.3998-4019. 10.1021/acs.jproteome.6b00400. hal-02191502 HAL Id: hal-02191502 https://hal.archives-ouvertes.fr/hal-02191502 Submitted on 19 Mar 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Journal of Proteome Research 1 2 3 Looking for missing proteins in the proteome of human spermatozoa: an 4 update 5 6 Yves Vandenbrouck1,2,3,#,§, Lydie Lane4,5,#, Christine Carapito6, Paula Duek5, Karine Rondel7, 7 Christophe Bruley1,2,3, Charlotte Macron6, Anne Gonzalez de Peredo8, Yohann Couté1,2,3, 8 Karima Chaoui8, Emmanuelle Com7, Alain Gateau5, AnneMarie Hesse1,2,3, Marlene 9 Marcellin8, Loren Méar7, Emmanuelle MoutonBarbosa8, Thibault Robin9, Odile Burlet- 10 Schiltz8, Sarah Cianferani6, Myriam Ferro1,2,3, Thomas Fréour10,11, Cecilia Lindskog12,Jérôme 11 1,2,3 7,§ 12 Garin , Charles Pineau .
  • Investigating Developmental and Functional Deficits in Neurodegenerative

    Investigating Developmental and Functional Deficits in Neurodegenerative

    UNIVERSITY OF CALIFORNIA, IRVINE Investigating developmental and functional deficits in neurodegenerative disease using transcriptomic analyses DISSERTATION submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Biomedical Sciences by Ryan Gar-Lok Lim Dissertation Committee: Professor Leslie M. Thompson, Chair Assistant Professor Dritan Agalliu Professor Peter Donovan Professor Suzanne Sandmeyer 2016 Introduction, Figure 1.1 © 2014 Macmillan Publishers Limited. Appendix 1 © 2016 Elsevier Ltd. All other materials © 2016 Ryan Gar-Lok Lim DEDICATION This dissertation is dedicated to my parents, sister, and my wife. I love you all very much and could not have accomplished any of this without your love and support. Please take the time to reflect back on all of the moments we’ve shared, and know, that it is because of those moments I have been able to succeed. This accomplishment is as much yours as it is mine. ii TABLE OF CONTENTS Page LIST OF FIGURES vi LIST OF TABLES ix ACKNOWLEDGMENTS x CURRICULUM VITAE xiii ABSTRACT OF THE DISSERTATION xv Introduction Huntington’s disease, the neurovascular unit and the blood-brain barrier 1 1.1 Huntington’s Disease 1.2 HTT structure and function 1.2.1 Normal HTT function and possible loss-of-function contributions to HD 1.3 mHTT pathogenesis 1.3.1 The dominant pathological features of mHTT - a gain-of- toxic function? 1.3.2 Cellular pathologies and non-neuronal contributions to HD 1.4 The neurovascular unit and the blood-brain barrier 1.4.1 Structure and function
  • MALE Protein Name Accession Number Molecular Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean H Mean PDAC Mean T-Test PDAC Vs. H T-Test

    MALE Protein Name Accession Number Molecular Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean H Mean PDAC Mean T-Test PDAC Vs. H T-Test

    MALE t-test t-test Accession Molecular H PDAC PDAC vs. PDAC vs. Protein Name Number Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean Mean Mean H CP PDAC/H PDAC/CP - 22 kDa protein IPI00219910 22 kDa 7 5 4 8 1 0 6 6 1 0.1126 0.0456 0.1 0.1 - Cold agglutinin FS-1 L-chain (Fragment) IPI00827773 12 kDa 32 39 34 26 53 57 36 30 55 0.0309 0.0388 1.8 1.5 - HRV Fab 027-VL (Fragment) IPI00827643 12 kDa 4 6 0 0 0 0 5 0 0 - 0.0574 - 0.0 - REV25-2 (Fragment) IPI00816794 15 kDa 8 12 5 7 8 9 10 6 8 0.2225 0.3844 1.3 0.8 A1BG Alpha-1B-glycoprotein precursor IPI00022895 54 kDa 115 109 106 112 111 100 112 109 105 0.6497 0.4138 1.0 0.9 A2M Alpha-2-macroglobulin precursor IPI00478003 163 kDa 62 63 86 72 14 18 63 79 16 0.0120 0.0019 0.2 0.3 ABCB1 Multidrug resistance protein 1 IPI00027481 141 kDa 41 46 23 26 52 64 43 25 58 0.0355 0.1660 2.4 1.3 ABHD14B Isoform 1 of Abhydrolase domain-containing proteinIPI00063827 14B 22 kDa 19 15 19 17 15 9 17 18 12 0.2502 0.3306 0.7 0.7 ABP1 Isoform 1 of Amiloride-sensitive amine oxidase [copper-containing]IPI00020982 precursor85 kDa 1 5 8 8 0 0 3 8 0 0.0001 0.2445 0.0 0.0 ACAN aggrecan isoform 2 precursor IPI00027377 250 kDa 38 30 17 28 34 24 34 22 29 0.4877 0.5109 1.3 0.8 ACE Isoform Somatic-1 of Angiotensin-converting enzyme, somaticIPI00437751 isoform precursor150 kDa 48 34 67 56 28 38 41 61 33 0.0600 0.4301 0.5 0.8 ACE2 Isoform 1 of Angiotensin-converting enzyme 2 precursorIPI00465187 92 kDa 11 16 20 30 4 5 13 25 5 0.0557 0.0847 0.2 0.4 ACO1 Cytoplasmic aconitate hydratase IPI00008485 98 kDa 2 2 0 0 0 0 2 0 0 - 0.0081 - 0.0
  • Experimental Eye Research 129 (2014) 93E106

    Experimental Eye Research 129 (2014) 93E106

    Experimental Eye Research 129 (2014) 93e106 Contents lists available at ScienceDirect Experimental Eye Research journal homepage: www.elsevier.com/locate/yexer Transcriptomic analysis across nasal, temporal, and macular regions of human neural retina and RPE/choroid by RNA-Seq S. Scott Whitmore a, b, Alex H. Wagner a, c, Adam P. DeLuca a, b, Arlene V. Drack a, b, Edwin M. Stone a, b, Budd A. Tucker a, b, Shemin Zeng a, b, Terry A. Braun a, b, c, * Robert F. Mullins a, b, Todd E. Scheetz a, b, c, a Stephen A. Wynn Institute for Vision Research, The University of Iowa, Iowa City, IA, USA b Department of Ophthalmology and Visual Sciences, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA c Department of Biomedical Engineering, College of Engineering, The University of Iowa, Iowa City, IA, USA article info abstract Article history: Proper spatial differentiation of retinal cell types is necessary for normal human vision. Many retinal Received 14 September 2014 diseases, such as Best disease and male germ cell associated kinase (MAK)-associated retinitis pigmen- Received in revised form tosa, preferentially affect distinct topographic regions of the retina. While much is known about the 31 October 2014 distribution of cell types in the retina, the distribution of molecular components across the posterior pole Accepted in revised form 4 November 2014 of the eye has not been well-studied. To investigate regional difference in molecular composition of Available online 5 November 2014 ocular tissues, we assessed differential gene expression across the temporal, macular, and nasal retina and retinal pigment epithelium (RPE)/choroid of human eyes using RNA-Seq.
  • Polyclonal Antibody to Carabin (N-Term) - Purified

    Polyclonal Antibody to Carabin (N-Term) - Purified

    OriGene Technologies, Inc. OriGene Technologies GmbH 9620 Medical Center Drive, Ste 200 Schillerstr. 5 Rockville, MD 20850 32052 Herford UNITED STATES GERMANY Phone: +1-888-267-4436 Phone: +49-5221-34606-0 Fax: +1-301-340-8606 Fax: +49-5221-34606-11 [email protected] [email protected] AP05728PU-N Polyclonal Antibody to Carabin (N-term) - Purified Alternate names: TBC1 domain family member 10C, TBC1D10C Quantity: 0.1 mg Concentration: 1.0 mg/ml Background: Carabin differs from other members of the TBC1 domain protein family, which appear to play a role in the regulation of cell growth and differentiation. Studies demonstrate that Carabin is part of a negative regulatory loop for the intracellular TCR signalling pathway and acts as an inhibitor of the Ras signalling pathway. Carabin is also believed to mediate crosstalk between calcineurin and Ras. Carabin is most abundantly expressed in spleen and peripheral blood leucocytes. Uniprot ID: Q8IV04 NCBI: NP_940919.1 GeneID: 374403 Host / Isotype: Rabbit / IgG Immunogen: A 17 amino acid peptide from near the amino terminus of human Carabin. Format: State: Liquid purified IgG Buffer System: Phosphate buffered saline containing 0.02% Sodium Azide (NaN3) Applications: Western blot: 1 - 2 µg/ml; detects a band of approximately 55kDa in human spleen tissue cell lysates. Immunohistochemistry on paraffin sections (requires antigen retrieval). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user. Specificity: This antibody recognises Carabin, also known as TBC1 domain family member 10C (TBC1D10C), a 50 kDa protein belonging to the TBC1 domain family of proteins.